The varicose vein treatment market size is expected to reach USD 2.61 billion by 2034, according to a new study by Polaris Market Research. The report “Varicose Vein Treatment Market Size, Share, Trends, Industry Analysis Report: By Type (Endovenous Ablation, Sclerotherapy, and Surgical Ligation & Stripping), Products, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The varicose vein treatment market growth is driven by an aging population, rising awareness of vascular health, and increasing demand for minimally invasive procedures. Key drivers include the growing prevalence of varicose veins due to factors such as aging, sedentary lifestyles, and genetic predisposition. Varicose vein treatment market opportunities lie in expanding treatment access, particularly in emerging markets, where improving healthcare infrastructure is driving demand. The rising shift toward noninvasive treatments, such as endovenous laser ablation and sclerotherapy, is a key trend, with advancements in technology improving treatment efficiency and patient outcomes.
The market also benefits from the rising cosmetic appeal of varicose vein treatments and improved insurance coverage. As a result, the varicose vein treatment market demand is expected to grow steadily, with increasing adoption of innovative, patient-friendly solutions and greater access to care.
Varicose Vein Treatment Market Report Highlights
By type, the endovenous ablation is the dominant segment, owing to its minimally invasive nature and quicker recovery times compared to traditional surgical methods. It is also the fastest-growing segment, with increasing patient preference for advanced, noninvasive treatments such as laser and radiofrequency ablation.
By end use, the vein clinics segment dominated the varicose vein treatment market share, driven by their specialization in vascular treatments and availability of noninvasive procedures. The ambulatory care units segment is experiencing the highest growth due to rising demand for outpatient treatments that offer cost-effective and convenient care.
North America dominates the global varicose vein treatment market revenue share, supported by advanced healthcare infrastructure and high adoption of minimally invasive procedures. However, Asia Pacific is the fastest-growing region, driven by expanding healthcare access, technological advancements, and increasing patient awareness.
A few key players in the market include Medtronic, Boston Scientific Corporation, AngioDynamics, Biolitec AG, Cook Medical, Sotrastan, Lumenis Ltd., Covidien (a Medtronic subsidiary), and Teleflex Incorporated.
Polaris Market Research has segmented the varicose vein treatment market report on the basis of type, products, end use, and region:
By Type Outlook (Revenue – USD Billion, 2020–2034)
Endovenous Ablation
Sclerotherapy
Surgical Ligation & Stripping
By Products Outlook (Revenue – USD Billion, 2020–2034)
Ablation Devices
Radiofrequency Ablation Devices
Laser Ablation Devices
Venous Closure Products
By End Use Outlook (Revenue – USD Billion, 2020–2034)
Vein Clinics
Hospitals
Ambulatory Care Unit
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook